Paricalcitol CAS#: 131918-61-1

Paricalcitol

Basic information Safety Related Supplier

Paricalcitol Basic information

Paricalcitol Chemical Properties

Safety Information

Paricalcitol Usage And Synthesis

DescriptionParicalcitol was launched as Zemplar in the US for the prevention and treatment of secondary hyperthyroidism associated with chronic renal failure. Paricalcitol is a synthetic vitamin D2, namely a novel 1-alpha-hydroxy-19-noranalogue in which the ring A exocyclic methylene group, typical of all vitamin D systems, has been replaced by two hydrogen atoms. Paricalcitol is the first vitamin D analogue marketed for this indication. In patients with chronic renal failure, Paricalcitol appreciably reduced levels of parathyroid hormone (PTH) without a significant difference in the incidence rate for hypercalcemia or hyperphosphatemia when compared with placebo.
Chemical PropertiesWhite Solid
OriginatorAbbott (US)
UsesSynthetic analog of vitamin D. Antihyperparathyroid.
UsesAntihyperparathyriod
Uses1,25-Dihydroxy vitamin D2 is a potent agonist of the vitamin D receptor. Paricalcitol is a synthetic 1,25-dihydroxy vitamin D2 analog. As vitamin D deficiency, associated with chronic kidney disease, leads to an increase in parathyroid hormone (secondary hyperparathyroidism), paricalcitol is used in renal patients to block parathyroid hormone overproduction. Vitamin D deficiency is also a risk factor in cancer, cardiovascular disease, hypertension, and diabetes, and paricalcitol may have applications in those contexts as well.
brand nameZemplar (Abbott).

Paricalcitol(131918-61-1)Related Product Information

ParicalcitolSupplierMore